Loading organizations...
§ Venture Capital · Lake Forest, IL, USA
Private equity firm investing in life sciences companies, providing hands-on expertise in development, operations, and commercialization.
Founded by Jack Schuler and John Patience, Crabtree Partners LLC is a private equity firm focused on life sciences investments, providing direct expertise in development, operations, and commercialization to build company value. The organization acquires equity stakes in emerging diagnostics and healthcare enterprises to drive sustained corporate growth and facilitate successful market exits. Crabtree Partners has a history of significant financial commitments, including a 2012 private equity investment of up to $35 million in Accelr8 Technology Corporation, where Larry Mehren was named the incoming chief executive officer. The principals have contributed to the substantial growth of associated portfolio companies, such as Stericycle reaching a $7.4 billion market capitalization and Ventana Medical Systems achieving a $3.4 billion acquisition by Roche. Additionally, other notable healthcare organizations associated with the firm and its board activities include Quidel Corporation and Medtronic.
Crabtree Partners has 2 tracked investments across 1 company. The latest tracked deal is $20.6M Other Equity in Neos Therapeutics in February 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 25, 2015 | Neos Therapeutics | $20.6M Other Equity | — | Burrill Life Sciences Capital Fund III, CAC, Delaware Street Capital, Essex Capital Corporation, Presidio Partners |
| Mar 4, 2014 | Neos Therapeutics | $15.5M Series C | — | Burrill Life Sciences Capital Fund III, CAC, CMEA Capital, Delaware Street Capital |